3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
11
Breast Neoplasms
10
Neoplasms
4
Osteoporosis
2
Melanoma
2
Cardiovascular Diseases
2
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Testicular Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Regional Osteoporosis as a Result of Chemotherapy
1
Primary Ovarian Insufficiency
1
Polycystic Ovary Syndrome
1
Paraganglioma, Extra-Adrenal
1
Pain
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasm Metastasis
1
Monoclonal Gammopathy of Undetermined Significance
1
Metabolic Syndrome
1
Menstruation Disturbances
1
Lymphedema
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Hematopoietic and Lymphoid System Neoplasm
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Depression
1
Cognitive Dysfunction
1
Interventions
Cisplatin
109
Radiotherapy
100
Fluorouracil
90
Paclitaxel
75
Oxaliplatin
63
Docetaxel
56
Carboplatin
55
Irinotecan
41
Esophagectomy
41
Leucovorin
40
Capecitabine
39
Surgical Procedures, Operative
36
Radiation
36
Drug Therapy
31
Neoadjuvant Therapy
25
Chemoradiotherapy
18
Cetuximab
18
S 1 (combination)
17
pembrolizumab
16
camrelizumab
16
Nivolumab
15
Magnetic Resonance Spectroscopy
15
Bevacizumab
15
Blood Specimen Collection
14
Surveys and Questionnaires
12
Radiotherapy, Intensity-Modulated
12
Immunotherapy
11
Epirubicin
11
Biopsy
11
Trastuzumab
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Esophageal Neoplasms
×
Absorptiometry, Photon
×
Clear all
NCT01742312
2016-02-18
Oeso-Chemo
University of Nottingham
Completed
25 enrolled